罫線.png

罫線1

250805_創薬サイエンス_バナーRGB_250-110.gif

創薬サイエンス

【AMED】日本薬学会第146年会.gif

日本医療研究開発機構

【UBE】_バナー広告_ロゴ.gif

UBE株式会社

東ソーロゴバナー（250px × 93px）.jpg

東ソー

【安井機械】banner_250x110.jpg

安井器械株式会社

【修正版】【BINDS】H110W250_日本薬学会第146年会_BINDSハ゛ナー広告_0212.png

BINDS

入稿データ_生命科学連携推進協議会.gif

生命科学連携推進協議会

General information

Overview

Access

Announcements(26)

Timetable

Fri. Mar 27, 2026

Sat. Mar 28, 2026

Sun. Mar 29, 2026

Program & Abstract

Sessions

Search presentations

Download PDF for print

Selected programs of presentations in English

Registration

Registration (Non-presenters, UG ≤ 4th Year)

Pharmaceutical International Meeting

For Participants

Participation Certificate PDF

Floor Guide

How to use "Confit mobile meeting app"

For Presenters

Exhibition

Companies（Equipment exhibits）

Companies（Medical supplies）

Companies (Literature Search Systems)

Companies（Books）

Abstract Submission (Oral/Poster Presentation)

Abstract Submission

146_head_en.png

app_icon.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Enter the password to view the abstracts. The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

General Session Category

Profile management

Bookmark

Announcements

From Hospital Formulation to Commercial Product: The Developmental Journey of Metronidazole Gel (Rozex® Gel) 0.75%

Co-sponsored by: The Pharmaceutical Society of Japan, The Academy of Pharmaceutical Science and Technology, Japan

Pharmacists engage in "preparing suspensions, disinfectants, and other formulations by crushing tablets, pulverizing solid dosage forms by opening capsules, and suspending them" as an extension of dispensing duties to satisfy pharmaceutical needs in healthcare settings. Such preparations have developed as "in-hospital formulations"—not commercially available but created as needed for therapeutic purposes. We determined that establishing the shelf life and storage conditions for these "in-hospital preparations" requires a basis grounded in the examination of their physicochemical properties. Furthermore, we concluded that establishing such quality control and clinical rationale is necessary not only for preparations used within medical institutions but also for those prepared and used in community pharmacies involved in home healthcare. Consequently, we expanded the term "in-hospital preparations" to encompass "clinical preparations." Regarding the preparation of in-hospital preparations, the "Guidelines for the Preparation and Use of In-Hospital Preparations" have been issued. However, compliance with these guidelines requires more specialized knowledge and skills. To ensure such expertise, various specialist pharmacist systems, such as oncology pharmacists and pharmacotherapy specialists, have been established, with many specialist pharmacists demonstrating their expertise in clinical settings. Therefore, at this symposium, held jointly with the Japanese Society of Pharmaceutical Sciences, we propose the establishment of a "Clinical Compounding Specialist Pharmacist" designation. This would enable pharmacists involved in clinical compounding to further demonstrate their capabilities as Pharmacist-Scientists. Through discussions with speakers and participants, we aim to explore the feasibility of establishing this designation.

Toward Establishing a "Clinical Pharmacy Specialist" Certification System —What Is Expected of Clinical Pharmacy Specialists?—

The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)

Presentation Information

[JS17-1]From Hospital Formulation to Commercial Product: The Developmental Journey of Metronidazole Gel (Rozex® Gel) 0.75%

Password required to view